Evaluation of weekly risedronate treatment in postmenopausal women with osteoprotegerin

Gulseren A., Peyman B., Pinar A.

PANMINERVA MEDICA, vol.53, no.2, pp.75-80, 2011 (SCI-Expanded) identifier

  • Publication Type: Article / Article
  • Volume: 53 Issue: 2
  • Publication Date: 2011
  • Journal Name: PANMINERVA MEDICA
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.75-80
  • Keywords: Osteoporosis, Menopause, Risedronic acid, SOLUBLE RECEPTOR ACTIVATOR, BONE-MINERAL DENSITY, FACTOR-KAPPA-B, SERUM OSTEOPROTEGERIN, CIRCULATING OSTEOPROTEGERIN, DISEASE-ACTIVITY, PAGETS-DISEASE, LIGAND, OSTEOPOROSIS, THERAPY
  • Marmara University Affiliated: Yes

Abstract

Aim. The aim of this study was to evaluate the effect of risedronate treatment on OPG, C-terminal cross-linking telopeptide of type 1 collagen (CTX), osteocalcin (OC), deoxypyridinoline (DPD), and to establish the correlation of OPG levels with other bone turnover markers.